Bannerman B, Xu L, Jones M, et al. (2011). Preclinical Evaluation of the Antitumor Activity of Bortezomib In Combination With Vitamin C or With Epigallocatechin Gallate, A Component of Green Tea. Cancer Chemotherapy and Pharmacology, 68(5) 1145-1154.


Berenson JR, Boccia R, Siegel D, et al. (2006). Efficacy and Safety of Melphalan, Arsenic Trioxide and Ascorbic Acid Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma: A Prospective, Multicentre, Phase II, Single-Arm StudyBritish Journal of Haematology, 135(2) 174-183.


Cullen JJ, Spitz DR, & Buettner GR (2011) Comment on “Pharmacologic Ascorbate Synergizes With Gemcitabine in Preclinical Models of Pancreatic Cancer,” i.e., All We Are Saying is, Give C a ChanceFree Radical Biology & Medicine, 50(12) 1726-7.


Fritz H, Flower G, Weeks L, et al. (2014) Intravenous Vitamin C and Cancer: A Systematic ReviewIntegrative Cancer Therapies, 13(4) 280-300


Hoffer LJ, Robitaille L, Zakarian R, et al. (2015) High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical TrialPLOS One, 10(4)


Jacobs C, Hutton B, Ng T, et al. (2015). Is There A Role for Oral or Intravenous Ascorbate (Vitamin C) in Treating Patients with Cancer? A Systematic ReviewThe Oncologist, 20(2) 210-23.


Kawada H, Sawanobori M, Tsuma-Kaneko M, et al. (2014) Phase I Clinical Trial of Intravenous L-ascorbic Acid Following Salvage Chemotherapy for Relapsed B-cell non-Hodgkin’s LymphomaThe Tokai Journal of Experimental and Clinical Medicine, 39(3) 111-5.


Leekha A, Gurjar BS, Tyagi A, et al. (2016) Vitamin C in Synergism With Cisplatin Induces Cell Death in Cervical Cancer Cells Through Altered Redox Cycling and p53 UpregulationJournal of Cancer Research and Clinical Oncology, 142(12) 2503-2514.


Ma Y, Chapman J, Levine M, et al. (2014) High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of ChemotherapyScience Translational Medicine, 6, 222.)


Monti DA, Mitchell E, Bazzan AJ, Littman S, et al. (2012) Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic CancerPLOS One, 7(1)


Moss R, (2006) Should Patients Undergoing Chemotherapy and Radiotherapy Be Prescribed Antioxidants? Integrative Cancer Therapies, 5(1) 63-82.


Muralikrishnan G, Amanullah S, Basha M, et al. (2010). Effect of Vitamin C On Lipidperoxidation and Antioxidant Status in Tamoxifen-Treated Breast Cancer PatientsChemotherapy, 56(4) 298-302.


Stephenson CM, Levin RD, Spector T, Lis CG (2013) Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of High-Dose Intravenous Ascorbic Acid in Patients with Advanced CancerCancer Chemotherapy and Pharmacology, 72(1) 139-146.


Vollbracht C, Schneider B, Leendert V, et al. (2011) Intravenous Vitamin C Administration Improves Quality of Life in Breast Cancer Patients During Chemo-/Radiotherapy and Aftercare: Results of a Retrospective, Multicentre, Epidemiological Cohort Study in GermanyIn Vivo, 25, (6) 383-990


Wagner SC, Markosian B, Ajili N, et al. (2014) Intravenous Ascorbic Acid As An Adjuvant to Interleukin-2 ImmunotherapyJournal of Translational Medicine, 12: 127